Ocugen

Ocugen is a clinical-stage biotechnology company focused on discovering, developing, and commercializing innovative therapies for rare and underserved eye diseases. The company specializes in ophthalmology research and is advancing a pipeline that includes gene therapies, biologic treatments, and other therapeutic technologies designed to address r... etinal and ocular surface disorders. Its research programs aim to develop novel solutions for conditions that currently have limited treatment options, with a particular emphasis on inherited retinal diseases and other vision-related disorders. Through scientific research, clinical development, and strategic collaborations, Ocugen works to bring new therapeutic approaches to patients while contributing to advancements in genetic and regenerative medicine within the ophthalmology field.Read More